Search results
Results from the WOW.Com Content Network
The Brazilian Health Regulatory Agency (Portuguese: Agência Nacional de Vigilância Sanitária, Anvisa, literally National Health Surveillance Agency) is a regulatory body of the Brazilian government, created in 1999 during President Fernando Henrique Cardoso's term of office.
The Brazilian Controlled Drugs and Substances Act (Portuguese: Regulamento Técnico sobre substâncias e medicamentos sujeitos a controle especial), officially Portaria nº 344/1998, [1] is Brazil's federal drug control statute, issued by the Ministry of Health through its National Health Surveillance Agency (Anvisa).
The Brazilian Nonproprietary Name or DCB, from the Portuguese Denominação Comum Brasileira is the official Portuguese nomenclature for drugs or active ingredients that have been approved by the Brazilian Health Regulatory Agency (ANVISA) for use in Brazil. [1] [2] The consolidated list from October 2021 contains just over 12,300 items. [3]
Agency for Medicinal Products and Medical Devices of Croatia Agencija za lijekove i medicinske proizvode (HALMED) 2016 Cyprus: Pharmaceutical Services (CyPHS) 2008 Czech Republic: State Institute for Drug Control Státní Ústav pro Kontrolu Léčiv (SÚKL) Institute for State Control of Veterinary Biologicals and Medicines (ISCVBM) 1997 2005 ...
The 2009 Brazilian Federal Law 11.903 and subsequent regulations of the National Agency for Sanitary Surveillance in Brazil (ANVISA) require that a 2D data matrix code be put on all secondary packaging. Under these provisions, manufacturers will be required to maintain a database of all transactions from manufacturing to dispensing, while ...
This is a list of organs of the federal government of Brazil that intend to regulate markets: Brazilian Electricity Regulatory Agency; Administrative Council for Economic Defense; National Health Surveillance Agency; Brazilian Agency of Telecommunications; National Agency of Petroleum, Natural Gas and Biofuels
In 2012, at the margins of the 65th World Health Assembly conference in May the Minister of Health of Brazil proposed an agenda to create a new coalition of Heads of Agency "to address current and emerging human medicine regulatory and safety challenges globally, strategically and in an ongoing, transparent, authoritative and institutional manner."
Language links are at the top of the page across from the title.